Pain after Discontinuation of Morphine Treatment Is Associated with Synaptic Increase of GluA4-Containing AMPAR in the Dorsal Horn of the Spinal Cord
Withdrawal from prescribed opioids results in increased pain sensitivity, which prolongs the treatment. This pain sensitivity is attributed to neuroplastic changes that converge at the spinal cord dorsal horn. We have recently reported that repeated morphine administration triggers an insertion of G...
Saved in:
Published in | Neuropsychopharmacology (New York, N.Y.) Vol. 38; no. 8; pp. 1472 - 1484 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Basingstoke
Nature Publishing Group
01.07.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Withdrawal from prescribed opioids results in increased pain sensitivity, which prolongs the treatment. This pain sensitivity is attributed to neuroplastic changes that converge at the spinal cord dorsal horn. We have recently reported that repeated morphine administration triggers an insertion of GluA2-lacking (Ca(2+)-permeable) α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPAR) in the hippocampus. This finding together with the reported involvement of AMPAR in the mechanisms underlying inflammatory pain led us to hypothesize a role for spinal AMPAR in opioid-induced pain behavior. Mice treated with escalating doses of morphine showed hypersensitivity to mechanical stimulation. Intrathecal administration of a Ca(2+)-permeable AMPAR selective blocker disrupted morphine-induced mechanical sensitivity. Analysis of the expression and phosphorylation levels of AMPAR subunits (GluA1/2/3/4) in homogenates and in postsynaptic density fractions from spinal cord dorsal horns showed an increase in GluA4 expression and phosphorylation in the postsynaptic density after morphine. Co-immunoprecipitation analyses suggested an increase in GluA4 homomers (Ca(2+)-permeable AMPAR) and immunohistochemical staining localized the increase in GluA4 levels in laminae III-V. The excitatory postsynaptic currents (EPSCs) recorded in laminae III-V showed enhanced sensitivity to Ca(2+)-permeable AMPAR blockers in morphine-treated mice. Furthermore, current-voltage relationships of AMPAR-mediated EPSCs showed that rectification index (an indicator of Ca(2+)-permeable AMPAR contribution) is increased in morphine-treated but not in saline-treated mice. These effects could be reversed by infusion of GluA4 antibody through patch pipette. This is the first direct evidence for a role of GluA4-containing AMPAR in morphine-induced pain and highlights spinal GluA4-containing AMPAR as targets to prevent the morphine-induced pain sensitivity. |
---|---|
AbstractList | Withdrawal from prescribed opioids results in increased pain sensitivity, which prolongs the treatment. This pain sensitivity is attributed to neuroplastic changes that converge at the spinal cord dorsal horn. We have recently reported that repeated morphine administration triggers an insertion of GluA2-lacking (Ca super(2+)-permeable) alpha -amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPAR) in the hippocampus. This finding together with the reported involvement of AMPAR in the mechanisms underlying inflammatory pain led us to hypothesize a role for spinal AMPAR in opioid-induced pain behavior. Mice treated with escalating doses of morphine showed hypersensitivity to mechanical stimulation. Intrathecal administration of a Ca super(2+)-permeable AMPAR selective blocker disrupted morphine-induced mechanical sensitivity. Analysis of the expression and phosphorylation levels of AMPAR subunits (GluA1/2/3/4) in homogenates and in postsynaptic density fractions from spinal cord dorsal horns showed an increase in GluA4 expression and phosphorylation in the postsynaptic density after morphine. Co-immunoprecipitation analyses suggested an increase in GluA4 homomers (Ca super(2+)-permeable AMPAR) and immunohistochemical staining localized the increase in GluA4 levels in laminae III-V. The excitatory postsynaptic currents (EPSCs) recorded in laminae III-V showed enhanced sensitivity to Ca super(2+)-permeable AMPAR blockers in morphine-treated mice. Furthermore, current-voltage relationships of AMPAR-mediated EPSCs showed that rectification index (an indicator of Ca super(2+)-permeable AMPAR contribution) is increased in morphine-treated but not in saline-treated mice. These effects could be reversed by infusion of GluA4 antibody through patch pipette. This is the first direct evidence for a role of GluA4-containing AMPAR in morphine-induced pain and highlights spinal GluA4-containing AMPAR as targets to prevent the morphine-induced pain sensitivity. Withdrawal from prescribed opioids results in increased pain sensitivity, which prolongs the treatment. This pain sensitivity is attributed to neuroplastic changes that converge at the spinal cord dorsal horn. We have recently reported that repeated morphine administration triggers an insertion of GluA2-lacking (Ca 2+ -permeable) α -amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPAR) in the hippocampus. This finding together with the reported involvement of AMPAR in the mechanisms underlying inflammatory pain led us to hypothesize a role for spinal AMPAR in opioid-induced pain behavior. Mice treated with escalating doses of morphine showed hypersensitivity to mechanical stimulation. Intrathecal administration of a Ca 2+ -permeable AMPAR selective blocker disrupted morphine-induced mechanical sensitivity. Analysis of the expression and phosphorylation levels of AMPAR subunits (GluA1/2/3/4) in homogenates and in postsynaptic density fractions from spinal cord dorsal horns showed an increase in GluA4 expression and phosphorylation in the postsynaptic density after morphine. Co-immunoprecipitation analyses suggested an increase in GluA4 homomers (Ca 2+ -permeable AMPAR) and immunohistochemical staining localized the increase in GluA4 levels in laminae III–V. The excitatory postsynaptic currents (EPSCs) recorded in laminae III–V showed enhanced sensitivity to Ca 2+ -permeable AMPAR blockers in morphine-treated mice. Furthermore, current–voltage relationships of AMPAR-mediated EPSCs showed that rectification index (an indicator of Ca 2+ -permeable AMPAR contribution) is increased in morphine-treated but not in saline-treated mice. These effects could be reversed by infusion of GluA4 antibody through patch pipette. This is the first direct evidence for a role of GluA4-containing AMPAR in morphine-induced pain and highlights spinal GluA4-containing AMPAR as targets to prevent the morphine-induced pain sensitivity. Withdrawal from prescribed opioids results in increased pain sensitivity, which prolongs the treatment. This pain sensitivity is attributed to neuroplastic changes that converge at the spinal cord dorsal horn. We have recently reported that repeated morphine administration triggers an insertion of GluA2-lacking (Ca(2+)-permeable) α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPAR) in the hippocampus. This finding together with the reported involvement of AMPAR in the mechanisms underlying inflammatory pain led us to hypothesize a role for spinal AMPAR in opioid-induced pain behavior. Mice treated with escalating doses of morphine showed hypersensitivity to mechanical stimulation. Intrathecal administration of a Ca(2+)-permeable AMPAR selective blocker disrupted morphine-induced mechanical sensitivity. Analysis of the expression and phosphorylation levels of AMPAR subunits (GluA1/2/3/4) in homogenates and in postsynaptic density fractions from spinal cord dorsal horns showed an increase in GluA4 expression and phosphorylation in the postsynaptic density after morphine. Co-immunoprecipitation analyses suggested an increase in GluA4 homomers (Ca(2+)-permeable AMPAR) and immunohistochemical staining localized the increase in GluA4 levels in laminae III-V. The excitatory postsynaptic currents (EPSCs) recorded in laminae III-V showed enhanced sensitivity to Ca(2+)-permeable AMPAR blockers in morphine-treated mice. Furthermore, current-voltage relationships of AMPAR-mediated EPSCs showed that rectification index (an indicator of Ca(2+)-permeable AMPAR contribution) is increased in morphine-treated but not in saline-treated mice. These effects could be reversed by infusion of GluA4 antibody through patch pipette. This is the first direct evidence for a role of GluA4-containing AMPAR in morphine-induced pain and highlights spinal GluA4-containing AMPAR as targets to prevent the morphine-induced pain sensitivity. |
Author | CABANERO, David CARLTON, Susan M BEAUDRY, Hélène SHENGTAI ZHOU YAN XIA IRIE, Takeshi MORON, Jose A BAKER, Alyssa MELYAN, Zara HARGETT, Gregory L GENDRON, Louis |
Author_xml | – sequence: 1 givenname: David surname: CABANERO fullname: CABANERO, David organization: Department of Anesthesiology, College of Physicians and Surgeons, Columbia University, New York, United States – sequence: 2 givenname: Alyssa surname: BAKER fullname: BAKER, Alyssa organization: Department of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, TX, United States – sequence: 3 givenname: Jose A surname: MORON fullname: MORON, Jose A organization: Department of Anesthesiology, College of Physicians and Surgeons, Columbia University, New York, United States – sequence: 4 surname: SHENGTAI ZHOU fullname: SHENGTAI ZHOU organization: Department of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, TX, United States – sequence: 5 givenname: Gregory L surname: HARGETT fullname: HARGETT, Gregory L organization: Department of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, TX, United States – sequence: 6 givenname: Takeshi surname: IRIE fullname: IRIE, Takeshi organization: Department of Anesthesiology, College of Physicians and Surgeons, Columbia University, New York, United States – sequence: 7 surname: YAN XIA fullname: YAN XIA organization: Department of Anesthesiology, College of Physicians and Surgeons, Columbia University, New York, United States – sequence: 8 givenname: Hélène surname: BEAUDRY fullname: BEAUDRY, Hélène organization: Département de Physiologie et Biophysique, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke,, Quebec, Canada – sequence: 9 givenname: Louis surname: GENDRON fullname: GENDRON, Louis organization: Département de Physiologie et Biophysique, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke,, Quebec, Canada – sequence: 10 givenname: Zara surname: MELYAN fullname: MELYAN, Zara organization: Department of Anesthesiology, College of Physicians and Surgeons, Columbia University, New York, United States – sequence: 11 givenname: Susan M surname: CARLTON fullname: CARLTON, Susan M organization: Department of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, TX, United States |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27477724$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/23403695$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkl1rFDEYhYNU7LZ65b0ERBBk1nxNZnJTGLbaLrRYbIXehXeymW7KbDImM0p_iP_XbLvWjyuvAm-enJPzcg7Qng_eIvSSkjklvH7vh2HOCOVzIZ-gGa0EKSQX13toRmrFC8r59T46SOmWEFpWsn6G9hkXhEtVztCPC3AeQzfaiI9dMsGPzk8wuuBx6PB5iMPaeYuvooVxY_2Ilwk3KQXjYLQr_N2Na3x552EYncFLbzKX7PbpST81olhkwezg_A1uzi-azzi7jWuLj0NM0OPTEO99tqPLwfk8WoS4eo6edtAn-2J3HqIvHz9cLU6Ls08ny0VzVpiSirEAuZKMd8KoFkARBsK0dMVKablgLaWCSCUoN61qW6IqXnagyq5WpWWkNUD5ITp60B2mdmNXJueL0Oshug3EOx3A6b9vvFvrm_BNc1kzKlgWeLsTiOHrZNOoN3mJtu_B2zAlTblSitaqrv4DlVVdE0JURl__g96GKebl3FM5k2Ilz9S7B8rEkFK03eO_KdHbZujcDL1thhYy06_-jPrI_qpCBt7sAEgG-i6CNy795ipRVRUT_Cc77cOs |
CODEN | NEROEW |
CitedBy_id | crossref_primary_10_1016_j_expneurol_2017_04_004 crossref_primary_10_1523_ENEURO_0091_15_2015 crossref_primary_10_3389_fphar_2020_620221 crossref_primary_10_1016_j_pharmthera_2021_108032 crossref_primary_10_1016_j_expneurol_2019_01_003 crossref_primary_10_3389_fnsyn_2021_748929 crossref_primary_10_1097_PR9_0000000000000573 crossref_primary_10_1021_acs_jmedchem_0c00901 crossref_primary_10_1016_j_neuropharm_2018_04_024 crossref_primary_10_1111_bph_14794 crossref_primary_10_1038_s41419_021_04233_2 crossref_primary_10_1016_j_pain_2013_05_033 crossref_primary_10_1016_j_peptides_2014_09_013 crossref_primary_10_1007_s11094_022_02635_w crossref_primary_10_1089_neu_2016_4562 crossref_primary_10_1111_bph_14911 crossref_primary_10_1097_j_pain_0000000000000124 crossref_primary_10_1038_s41586_023_06678_1 crossref_primary_10_3389_fnmol_2018_00382 crossref_primary_10_3389_fnsys_2022_1014768 |
Cites_doi | 10.1097/ALN.0b013e3181bfab61 10.1016/j.jneumeth.2011.04.036 10.1523/JNEUROSCI.4514-08.2009 10.1016/j.neuroscience.2008.08.042 10.1016/0304-3959(83)90201-4 10.1016/j.pain.2007.07.001 10.1016/j.neuropharm.2003.08.008 10.1016/j.jpain.2008.10.003 10.1074/mcp.M600184-MCP200 10.1073/pnas.0611698104 10.1016/j.neuroscience.2006.08.077 10.1186/1744-8069-4-7 10.1111/j.1600-0854.2006.00521.x 10.1016/j.brainres.2009.10.041 10.1042/BST0331354 10.1186/1744-8069-4-5 10.1016/j.jpain.2005.08.001 10.1523/JNEUROSCI.2391-10.2010 10.1111/j.1460-9568.2009.06633.x 10.1523/JNEUROSCI.4053-08.2008 10.1038/nn997 10.1016/j.pain.2011.01.016 10.1038/nrrheum.2010.24 10.1097/ALN.0b013e31820efb19 10.1097/00000542-200603000-00025 10.1016/0165-0270(94)90144-9 10.1016/j.jpain.2009.06.012 10.1016/j.pain.2009.09.030 10.1523/JNEUROSCI.21-11-03715.2001 10.1523/JNEUROSCI.3835-11.2011 10.1016/j.pain.2010.07.017 10.1146/annurev.neuro.25.112701.142758 10.1523/JNEUROSCI.21-16-06105.2001 10.1016/j.neuroscience.2006.09.005 10.1126/science.1171759 10.1172/JCI44911 10.1016/j.pain.2006.09.033 10.1124/mol.109.060301 10.1016/j.molbrainres.2005.04.004 10.1113/jphysiol.2006.110072 10.1523/JNEUROSCI.1237-04.2004 |
ContentType | Journal Article |
Copyright | 2014 INIST-CNRS Copyright Nature Publishing Group Jul 2013 Copyright © 2013 American College of Neuropsychopharmacology 2013 American College of Neuropsychopharmacology |
Copyright_xml | – notice: 2014 INIST-CNRS – notice: Copyright Nature Publishing Group Jul 2013 – notice: Copyright © 2013 American College of Neuropsychopharmacology 2013 American College of Neuropsychopharmacology |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7TK 7X7 7XB 88E 88G 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2M M7P PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 7U7 C1K 5PM |
DOI | 10.1038/npp.2013.46 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection (Proquest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Psychology Database (ProQuest) Biological Science Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic Toxicology Abstracts Environmental Sciences and Pollution Management PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest One Psychology ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic Toxicology Abstracts Environmental Sciences and Pollution Management |
DatabaseTitleList | Toxicology Abstracts MEDLINE ProQuest One Psychology |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | Spinal AMPAR mediate morphine hypersensitivity |
EISSN | 1740-634X |
EndPage | 1484 |
ExternalDocumentID | 2994665141 10_1038_npp_2013_46 23403695 27477724 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GeographicLocations | New York Canada United States--US |
GeographicLocations_xml | – name: New York – name: Canada – name: United States--US |
GrantInformation_xml | – fundername: NIDA NIH HHS grantid: DA025036 – fundername: NIAMS NIH HHS grantid: P30 AR044535 – fundername: NIDA NIH HHS grantid: R01 DA027460 – fundername: NIDA NIH HHS grantid: F30 DA032298 – fundername: NIDA NIH HHS grantid: R01 DA025036 – fundername: NIDA NIH HHS grantid: DA027460 |
GroupedDBID | --- --K -DZ -Q- 0R~ 1B1 29N 2WC 36B 39C 3V. 4.4 53G 5RE 5VS 70F 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AADWK AAEDT AALRI AANZL AAPBV AAQFI AAQXK AAWBL AAXUO AAYJO AAZLF ABDEU ABFLS ABGIJ ABIVO ABLJU ABMAC ABPTK ABUWG ACBMV ACBRV ACBYP ACGFO ACGFS ACIGE ACIUM ACKTT ACPRK ACRQY ACTTH ACVWB ADBBV ADFRT ADHDB ADMDM ADQMX ADYYL AEDAW AEFTE AEJRE AENEX AEXYK AFKRA AFRAH AFSHS AGAYW AGEZK AGGBP AGHAI AHMBA AHSBF AILAN AJDOV AJRNO ALFFA ALMA_UNASSIGNED_HOLDINGS AMRJV AMYLF AOIJS ASPBG AVWKF AZFZN AZQEC BAWUL BBAFP BBNVY BENPR BHPHI BPHCQ BVXVI CAG COF CS3 DIK DNIVK DWQXO E3Z EBLON EBS EE. EIOEI EJD EMB EMOBN F5P FDB FDQFY FEDTE FERAY FGOYB FIZPM FSGXE FYUFA GNUQQ GX1 HCIFZ HVGLF HYE HZ~ IHE IPNFZ IQODW JSO JZLTJ KQ8 M1P M2M M41 M7P MK0 NAO NQ- NQJWS NYICJ O9- OK1 P2P P6G PQEST PQQKQ PQUKI PROAC PSQYO Q2X R2- RIG RNS RNT RNTTT ROL RPM RPZ SEW SNX SNYQT SRMVM SSZ SV3 SWTZT TAOOD TBHMF TDRGL TR2 UKHRP W2D ZGI ZKB 406 AACDK AASML AATNV ABAKF ABZZP ACAOD ACMJI ACZOJ ADMUD AEFQL AEMSY AESKC AEVLU AFBBN AGQEE AIGIU ALIPV CCPQU CGR CUY CVF DPUIP ECM EIF FIGPU HMCUK IWAJR LGEZI LOTEE NADUK NPM NXXTH PSYQQ SOHCF AAYXX CITATION 7TK 7XB 8FE 8FH 8FK K9. LK8 PRINS Q9U 7X8 7U7 C1K 5PM |
ID | FETCH-LOGICAL-c514t-a6d623f4c9baa902a4cb1d256e342b114069413cb9bb09735fa95f895e20bca13 |
IEDL.DBID | RPM |
ISSN | 0893-133X |
IngestDate | Tue Sep 17 21:20:33 EDT 2024 Fri Aug 16 08:07:38 EDT 2024 Sat Aug 17 03:03:43 EDT 2024 Fri Sep 13 08:02:33 EDT 2024 Thu Sep 26 17:09:42 EDT 2024 Sat Sep 28 07:53:28 EDT 2024 Thu Nov 24 18:29:59 EST 2022 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | Spinal cord Synapse Pain Treatment Central nervous system GluA4 Opiates Morphine Drug of abuse Narcotic analgesic Posterior spinal horn AMPAR |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c514t-a6d623f4c9baa902a4cb1d256e342b114069413cb9bb09735fa95f895e20bca13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 These authors contributed equally. |
OpenAccessLink | https://www.nature.com/articles/npp201346.pdf |
PMID | 23403695 |
PQID | 1366949253 |
PQPubID | 33935 |
PageCount | 13 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3682142 proquest_miscellaneous_1399918987 proquest_miscellaneous_1367880009 proquest_journals_1366949253 crossref_primary_10_1038_npp_2013_46 pubmed_primary_23403695 pascalfrancis_primary_27477724 |
PublicationCentury | 2000 |
PublicationDate | 2013-07-01 |
PublicationDateYYYYMMDD | 2013-07-01 |
PublicationDate_xml | – month: 07 year: 2013 text: 2013-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Basingstoke |
PublicationPlace_xml | – name: Basingstoke – name: England – name: New York |
PublicationTitle | Neuropsychopharmacology (New York, N.Y.) |
PublicationTitleAlternate | Neuropsychopharmacology |
PublicationYear | 2013 |
Publisher | Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group |
References | 17028301 - Mol Cell Proteomics. 2007 Jan;6(1):29-42 11734620 - Pharmacol Rev. 2001 Dec;53(4):597-652 20696523 - Pain. 2010 Oct;151(1):226-34 20159947 - Mol Pharmacol. 2010 May;77(5):874-83 18809472 - Neuroscience. 2008 Oct 28;156(4):872-84 19853381 - Pain. 2009 Dec 15;147(1-3):265-76 15908039 - Brain Res Mol Brain Res. 2005 Jul 29;138(1):94-103 17233759 - Traffic. 2007 Mar;8(3):259-69 19712899 - J Pain. 2009 Sep;10(9):895-926 21368652 - Anesthesiology. 2011 May;114(5):1180-9 12052905 - Annu Rev Neurosci. 2002;25:103-26 17360685 - Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3579-84 17123731 - Pain. 2007 May;129(1-2):35-45 19590003 - Science. 2009 Jul 10;325(5937):207-10 16246117 - Biochem Soc Trans. 2005 Dec;33(Pt 6):1354-6 22072679 - J Neurosci. 2011 Nov 9;31(45):16279-91 18215271 - Mol Pain. 2008;4:5 19279258 - J Neurosci. 2009 Mar 11;29(10):3206-19 17055663 - Neuroscience. 2007 Jan 5;144(1):263-74 21383497 - J Clin Invest. 2011 Apr;121(4):1608-23 19854164 - Brain Res. 2010 Jan 13;1308:58-67 17826911 - Pain. 2008 May;136(1-2):158-67 21282008 - Pain. 2011 Apr;152(4):912-23 18294378 - Mol Pain. 2008;4:7 16414554 - J Pain. 2006 Jan;7(1):43-8 20357788 - Nat Rev Rheumatol. 2010 Apr;6(4):191-7 11487634 - J Neurosci. 2001 Aug 15;21(16):6105-14 17097234 - Neuroscience. 2007 Jan 5;144(1):88-99 14680764 - Neuropharmacology. 2004 Feb;46(2):264-72 21571003 - J Neurosci Methods. 2011 Jul 15;199(1):62-8 6877845 - Pain. 1983 Jun;16(2):109-10 19200070 - Eur J Neurosci. 2009 Feb;29(4):718-26 12536214 - Nat Neurosci. 2003 Feb;6(2):136-43 16508405 - Anesthesiology. 2006 Mar;104(3):570-87 21084596 - J Neurosci. 2010 Nov 17;30(46):15400-8 19052206 - J Neurosci. 2008 Dec 3;28(49):13150-60 11356858 - J Neurosci. 2001 Jun 1;21(11):3715-20 19101210 - J Pain. 2009 Mar;10(3):316-22 19934880 - Anesthesiology. 2009 Dec;111(6):1334-45 16763002 - J Physiol. 2006 Aug 15;575(Pt 1):133-44 15215299 - J Neurosci. 2004 Jun 23;24(25):5766-77 7990513 - J Neurosci Methods. 1994 Jul;53(1):55-63 LF Chu (BFnpp201346_CR11) 2006; 7 O Kopach (BFnpp201346_CR19) 2011; 152 D Le Bars (BFnpp201346_CR21) 2001; 53 DY Liang (BFnpp201346_CR23) 2011; 114 M Narita (BFnpp201346_CR29) 2001; 21 AR Gomes (BFnpp201346_CR17) 2007; 8 JL Hay (BFnpp201346_CR18) 2009; 10 L Gendron (BFnpp201346_CR16) 2007; 144 JA Moron (BFnpp201346_CR26) 2007; 6 SL Buldakova (BFnpp201346_CR5) 2007; 144 C Muscoli (BFnpp201346_CR27) 2010; 30 LJ Crofford (BFnpp201346_CR12) 2010; 6 JS Park (BFnpp201346_CR31) 2009; 29 MS Angst (BFnpp201346_CR1) 2006; 104 E Polgar (BFnpp201346_CR32) 2008; 28 R Drdla (BFnpp201346_CR13) 2009; 325 A Latremoliere (BFnpp201346_CR20) 2009; 10 S Okabe (BFnpp201346_CR30) 2001; 21 DH Youn (BFnpp201346_CR40) 2008; 136 JA Esteban (BFnpp201346_CR14) 2003; 6 D Liang (BFnpp201346_CR22) 2008; 4 S Chakrabarti (BFnpp201346_CR9) 2005; 138 V Gangadharan (BFnpp201346_CR15) 2011; 121 S Tumati (BFnpp201346_CR37) 2011; 199 HY Man (BFnpp201346_CR25) 2007; 104 J Boehm (BFnpp201346_CR4) 2005; 33 SM Carlton (BFnpp201346_CR7) 2009; 147 LP Vera-Portocarrero (BFnpp201346_CR38) 2007; 129 D Cabañero (BFnpp201346_CR6) 2009; 111 Z Zheng (BFnpp201346_CR41) 2008; 156 CK Tong (BFnpp201346_CR36) 2006; 575 Y Xia (BFnpp201346_CR39) 2011; 31 FE Atianjoh (BFnpp201346_CR2) 2010; 151 GG Nagy (BFnpp201346_CR28) 2004; 24 M Zimmermann (BFnpp201346_CR42) 1983; 16 AJ Todd (BFnpp201346_CR35) 2009; 29 E Célérier (BFnpp201346_CR8) 2004; 46 SR Chaplan (BFnpp201346_CR10) 1994; 53 SK Billa (BFnpp201346_CR3) 2010; 77 R Malinow (BFnpp201346_CR24) 2002; 25 E Polgar (BFnpp201346_CR33) 2008; 4 E Polgar (BFnpp201346_CR34) 2010; 1308 |
References_xml | – volume: 111 start-page: 1334 year: 2009 ident: BFnpp201346_CR6 publication-title: Anesthesiology doi: 10.1097/ALN.0b013e3181bfab61 contributor: fullname: D Cabañero – volume: 199 start-page: 62 year: 2011 ident: BFnpp201346_CR37 publication-title: J Neurosci Methods doi: 10.1016/j.jneumeth.2011.04.036 contributor: fullname: S Tumati – volume: 29 start-page: 3206 year: 2009 ident: BFnpp201346_CR31 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4514-08.2009 contributor: fullname: JS Park – volume: 156 start-page: 872 year: 2008 ident: BFnpp201346_CR41 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2008.08.042 contributor: fullname: Z Zheng – volume: 16 start-page: 109 year: 1983 ident: BFnpp201346_CR42 publication-title: Pain doi: 10.1016/0304-3959(83)90201-4 contributor: fullname: M Zimmermann – volume: 136 start-page: 158 year: 2008 ident: BFnpp201346_CR40 publication-title: Pain doi: 10.1016/j.pain.2007.07.001 contributor: fullname: DH Youn – volume: 46 start-page: 264 year: 2004 ident: BFnpp201346_CR8 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2003.08.008 contributor: fullname: E Célérier – volume: 53 start-page: 597 year: 2001 ident: BFnpp201346_CR21 publication-title: Pharmacol Rev contributor: fullname: D Le Bars – volume: 10 start-page: 316 year: 2009 ident: BFnpp201346_CR18 publication-title: J Pain doi: 10.1016/j.jpain.2008.10.003 contributor: fullname: JL Hay – volume: 6 start-page: 29 year: 2007 ident: BFnpp201346_CR26 publication-title: Mol Cell Proteomics doi: 10.1074/mcp.M600184-MCP200 contributor: fullname: JA Moron – volume: 104 start-page: 3579 year: 2007 ident: BFnpp201346_CR25 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0611698104 contributor: fullname: HY Man – volume: 144 start-page: 263 year: 2007 ident: BFnpp201346_CR16 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2006.08.077 contributor: fullname: L Gendron – volume: 4 start-page: 7 year: 2008 ident: BFnpp201346_CR22 publication-title: Mol Pain doi: 10.1186/1744-8069-4-7 contributor: fullname: D Liang – volume: 8 start-page: 259 year: 2007 ident: BFnpp201346_CR17 publication-title: Traffic doi: 10.1111/j.1600-0854.2006.00521.x contributor: fullname: AR Gomes – volume: 1308 start-page: 58 year: 2010 ident: BFnpp201346_CR34 publication-title: Brain Res doi: 10.1016/j.brainres.2009.10.041 contributor: fullname: E Polgar – volume: 33 start-page: 1354 year: 2005 ident: BFnpp201346_CR4 publication-title: Biochem Soc Trans doi: 10.1042/BST0331354 contributor: fullname: J Boehm – volume: 4 start-page: 5 year: 2008 ident: BFnpp201346_CR33 publication-title: Mol Pain doi: 10.1186/1744-8069-4-5 contributor: fullname: E Polgar – volume: 7 start-page: 43 year: 2006 ident: BFnpp201346_CR11 publication-title: J Pain doi: 10.1016/j.jpain.2005.08.001 contributor: fullname: LF Chu – volume: 30 start-page: 15400 year: 2010 ident: BFnpp201346_CR27 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2391-10.2010 contributor: fullname: C Muscoli – volume: 29 start-page: 718 year: 2009 ident: BFnpp201346_CR35 publication-title: Eur J Neurosci doi: 10.1111/j.1460-9568.2009.06633.x contributor: fullname: AJ Todd – volume: 28 start-page: 13150 year: 2008 ident: BFnpp201346_CR32 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4053-08.2008 contributor: fullname: E Polgar – volume: 6 start-page: 136 year: 2003 ident: BFnpp201346_CR14 publication-title: Nat Neurosci doi: 10.1038/nn997 contributor: fullname: JA Esteban – volume: 152 start-page: 912 year: 2011 ident: BFnpp201346_CR19 publication-title: Pain doi: 10.1016/j.pain.2011.01.016 contributor: fullname: O Kopach – volume: 6 start-page: 191 year: 2010 ident: BFnpp201346_CR12 publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2010.24 contributor: fullname: LJ Crofford – volume: 114 start-page: 1180 year: 2011 ident: BFnpp201346_CR23 publication-title: Anesthesiology doi: 10.1097/ALN.0b013e31820efb19 contributor: fullname: DY Liang – volume: 104 start-page: 570 year: 2006 ident: BFnpp201346_CR1 publication-title: Anesthesiology doi: 10.1097/00000542-200603000-00025 contributor: fullname: MS Angst – volume: 53 start-page: 55 year: 1994 ident: BFnpp201346_CR10 publication-title: J Neurosci Methods doi: 10.1016/0165-0270(94)90144-9 contributor: fullname: SR Chaplan – volume: 10 start-page: 895 year: 2009 ident: BFnpp201346_CR20 publication-title: J Pain doi: 10.1016/j.jpain.2009.06.012 contributor: fullname: A Latremoliere – volume: 147 start-page: 265 year: 2009 ident: BFnpp201346_CR7 publication-title: Pain doi: 10.1016/j.pain.2009.09.030 contributor: fullname: SM Carlton – volume: 21 start-page: 3715 year: 2001 ident: BFnpp201346_CR29 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.21-11-03715.2001 contributor: fullname: M Narita – volume: 31 start-page: 16279 year: 2011 ident: BFnpp201346_CR39 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.3835-11.2011 contributor: fullname: Y Xia – volume: 151 start-page: 226 year: 2010 ident: BFnpp201346_CR2 publication-title: Pain doi: 10.1016/j.pain.2010.07.017 contributor: fullname: FE Atianjoh – volume: 25 start-page: 103 year: 2002 ident: BFnpp201346_CR24 publication-title: Annu Rev Neurosci doi: 10.1146/annurev.neuro.25.112701.142758 contributor: fullname: R Malinow – volume: 21 start-page: 6105 year: 2001 ident: BFnpp201346_CR30 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.21-16-06105.2001 contributor: fullname: S Okabe – volume: 144 start-page: 88 year: 2007 ident: BFnpp201346_CR5 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2006.09.005 contributor: fullname: SL Buldakova – volume: 325 start-page: 207 year: 2009 ident: BFnpp201346_CR13 publication-title: Science doi: 10.1126/science.1171759 contributor: fullname: R Drdla – volume: 121 start-page: 1608 year: 2011 ident: BFnpp201346_CR15 publication-title: J Clin Invest doi: 10.1172/JCI44911 contributor: fullname: V Gangadharan – volume: 129 start-page: 35 year: 2007 ident: BFnpp201346_CR38 publication-title: Pain doi: 10.1016/j.pain.2006.09.033 contributor: fullname: LP Vera-Portocarrero – volume: 77 start-page: 874 year: 2010 ident: BFnpp201346_CR3 publication-title: Mol Pharmacol doi: 10.1124/mol.109.060301 contributor: fullname: SK Billa – volume: 138 start-page: 94 year: 2005 ident: BFnpp201346_CR9 publication-title: Brain Res Mol Brain Res doi: 10.1016/j.molbrainres.2005.04.004 contributor: fullname: S Chakrabarti – volume: 575 start-page: 133 year: 2006 ident: BFnpp201346_CR36 publication-title: J Physiol doi: 10.1113/jphysiol.2006.110072 contributor: fullname: CK Tong – volume: 24 start-page: 5766 year: 2004 ident: BFnpp201346_CR28 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1237-04.2004 contributor: fullname: GG Nagy |
SSID | ssj0015768 |
Score | 2.2430701 |
Snippet | Withdrawal from prescribed opioids results in increased pain sensitivity, which prolongs the treatment. This pain sensitivity is attributed to neuroplastic... |
SourceID | pubmedcentral proquest crossref pubmed pascalfrancis |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 1472 |
SubjectTerms | Anesthesiology Animals Biological and medical sciences Laboratory animals Male Medical sciences Mice Mice, Inbred C57BL Morphine Morphine - administration & dosage Narcotics Original Pain Pain - metabolism Pain - pathology Pain Measurement - methods Phosphorylation Posterior Horn Cells - metabolism Posterior Horn Cells - pathology Receptors, AMPA - metabolism Spinal cord Synapses - metabolism Synapses - pathology Treatment Outcome |
SummonAdditionalLinks | – databaseName: Health & Medical Collection (Proquest) dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwED6NISGkCUEHLDAmI017WmgTOz_8hKKNUZCKKtZJfYscxxGVIAlN-9A_hP-XOydpV4T2mjixkzufv7PvvgM4L4SJjIyMGxHPkPBi7SoVCDcII0_nowDFTonCk2_h-E58nQfzAxj3uTAUVtnbRGuo80rTHvnQ42EoiUmPD1VGuwB6NfxY_3apfhSds3bFNB7BY89HWIGaHc23rpdHqNriScld9MrmXabeiMfDsibaSo9_IAx8b206qlWDv6lo61v8D4D-G0d5b2G6eQ7POkTJklYFXsCBKQdwnJToTf_asAtmYzzt5vkAnky6o_QBXExb0urNJZvtcrCaS_vEls56cwx_pmpRMltLnF0vGoptX5QtQTirCjapUFL4RjbrQ9bZl4b1Ujc5o51edrspFRonzdAeURi8oUc__1wnwiV-rLZMBUsm0-Q7w94QlbLratngd42rpe2HLt3WVMOLXaHD_BLubj7NrsZuV8zB1YjJVq4Kc0RahdAyU0qOfCV05uUIuAwXfoZeGWXgelxnMsuIQigolAyKWAbGH2VaefwVHJZVaU6AUWwMelleoPxC5EIogQtOUWShDgzqZO7AeS_GtG45O1J71s7jFKWdkrRTETpwtifibVty1NHpEA6c9jJPu5ndpDs9dOD99jbOSTpoUaWp1rZNhHYR4etDbQiaxzKOHHjdqtFuAFwgsJCBA9Gegm0bECf4_p1y8cNyg_MwJhK9Nw8P_S089W1ZDwo7PoXD1XJt3iG4WmVndt78BU4fJsE priority: 102 providerName: ProQuest |
Title | Pain after Discontinuation of Morphine Treatment Is Associated with Synaptic Increase of GluA4-Containing AMPAR in the Dorsal Horn of the Spinal Cord |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23403695 https://www.proquest.com/docview/1366949253/abstract/ https://search.proquest.com/docview/1367880009 https://search.proquest.com/docview/1399918987 https://pubmed.ncbi.nlm.nih.gov/PMC3682142 |
Volume | 38 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swED7aDsZgjC3dD29d0KD0qU5iS_KPxyxtlw1SQptC3oxsyyzQyCFuHvKH7P_dnWynzRh72Kst2UpOJ31nffcdwGkhdKjjULsh6QwJL8pcpaRwZRB6WT6QaHZKFJ5cB-M78WMu5wcg21wYS9rP0kXP3C97ZvHTcitXy6zf8sT608mIBxEphfUP4TDkvA3Rm6MDAtAWOsbcxQBs3iTlDXjUNytSqPR4T1DlIp8LXL6psMSTHenlSlX45xR1VYu_wc4_2ZNPtqOr1_CqwZFsWI_3DRxo04HjocEYerllZ8wyO-0n8w48nzQH6B04m9ZS1dtzNnvMvKrObY-diPX2GH5N1cIwW0GcXSwqYrQvTC0LzsqCTUq0Dz6RzVqiOvtesdbWOmf0fZfdbo3CJSljuAoR-V1T12_3m6FwSRWrLk7BhpPp8Ibh2xCLsotyXeHvGpdr-x66dLuiyl1shGHyW7i7upyNxm5TwsHNEIk9uCrIEV8VIotTpeKBr0SWejnCLM2Fn2IsRnm3Hs_SOE1JOEgWKpZFFEvtD9JMefwdHJnS6A_AiBGDsZUnlV-IXAglcJspijTIpMaZmDtw2poxWdVKHYk9YedRgoZPyPCJCBzo7pl415bCcww1hAMnrc2Txp-rxOMBDjT2JXfgy-42eiIdryijy41tE-JqiKD1X20IkEdxFDrwvp5GjwNo5qMD4d4E2zUgJfD9O-ggVhG8cYiP_93zE7zwbZ0P4iGfwNHDeqM_I9p6SLvoY_OwC8--Xl5Pb7rW134Dx_0uaQ |
link.rule.ids | 230,315,733,786,790,891,12083,21416,27957,27958,31754,31755,33779,33780,43345,43840,53827,53829,74102,74659 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1db9MwFL2CIcEkhKDjIzCGkaY9LayJna8nFG2MDpapYp3Ut8hJHFFpOKFpH_pD-L_c6yTtitBeG6dJe-zrc-3jcwEOS6ECFQXKDshnSDhhbkvpCdvzAycvhh7CTgeFkyt_dCO-Tb1pt-DWdLLKPiaaQF1UOa2Rnzjc9yNy0uOf6982VY2i3dWuhMZDeCQ4FyTpC6brhMshLm1YZMRtzMWm3fm8IQ9PdE1mlQ7_RMz3zoz0tJYN_jllW9Xif7TzX_Xkneno_Dk863gki1vgX8ADpQewF2vMoX-t2BEzyk6zZD6Ax0m3gT6Ao3FrVb06ZpPNyavm2NyxNrFe7cGfsZxpZiqIs7NZQ4r2mW5twVlVsqRCfPAb2aQXqrOLhvVYq4LR-i67XmmJISlnGIVI_K7o1q-3y1jY5IrVFqdgcTKOfzB8GnJRdlbNG_xdo2punkMfXddUuYudYpr8Em7Ov0xOR3ZXwsHOkYktbOkXyK9KkUeZlNHQlSLPnAJpluLCzTAXo3O3Ds-zKMvIOMgrZeSVYeQpd5jl0uGvYEdXWr0BRooYzK0cT7qlKISQAqeZssz83FPYEwsLDnsY07p16kjNDjsPU0Q7JbRT4VtwsAXxui2l55hqCAv2e8zTbjw36ab3WfBxfRlHIm2vSK2qpWkTYDRE0npfGyLkYRQGFrxuu9HmBbhAOhF5FgRbHWzdgJzAt6_o2U_jCM79kKzz3t7_6h_gyWiSXKaXF1ff38Guawp7kPB4H3YW86V6j_RqkR2YMfQXfq0l9A |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwED7BJk1ICEEHIzCGkaY9LbSp7fx4QmFd6YBW1dZJfYucxBGVWNI17UP_EP5f7pykXRHaa-M0ae98_s73-TuA00xoTweetj3SGRKOn9hKSWFL13OStCPR7HRQeDhyB7fi-1ROa_5TWdMqm5hoAnVaJLRH3na46wakpMfbWU2LGPf6X-b3NnWQokpr3U7jKex7wpXo4ftfL0fj601NgZC1wZQBtzEzm9an9Trcb-dzkq50-GfCwQ_Wp-dzVeJflVU9Lv4HQv_lUj5YnPov4UWNKllYucEreKLzFhyGOWbUd2t2xgzP02ygt-BgWJfTW3A2roSr1-dssj2HVZ6bOzaS1utD-DNWs5yZfuKsNyuJ3z7LK5FwVmRsWKC18BvZpKGts6uSNZbXKaPdXnazzhUGqIRhTCIqvKZbv_1ehcImjayqVQULh-PwmuHTEJmyXrEo8XcNioV5Dn10M6c-XuwCk-bXcNu_nFwM7Lqhg50gLlvayk0RbWUiCWKlgk5XiSR2UgRdmotujJkZncJ1eBIHcUwyQjJTgcz8QOpuJ06Uw9_AXl7k-i0w4sdgpuVI1c1EKoQSuOhkWewmUqNfphacNmaM5pVuR2Tq7dyP0NoRWTsSrgUnOybejKVkHRMPYcFxY_Oont1ltPVFCz5tLuO8pGKLynWxMmM8jI0IYR8bQ_DcD3zPgqPKjbYvwAWCi0Ba4O042GYA6YLvXslnv4w-OHd9EtJ79_irf4QDnEDRz6vRj_fwrGu6fBAL-Rj2louV_oBYaxmf1JPoL0F7K5c |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pain+after+discontinuation+of+morphine+treatment+is+associated+with+synaptic+increase+of+GluA4-containing+AMPAR+in+the+dorsal+horn+of+the+spinal+cord&rft.jtitle=Neuropsychopharmacology+%28New+York%2C+N.Y.%29&rft.au=Caba%C3%B1ero%2C+David&rft.au=Baker%2C+Alyssa&rft.au=Zhou%2C+Shengtai&rft.au=Hargett%2C+Gregory+L&rft.date=2013-07-01&rft.eissn=1740-634X&rft.volume=38&rft.issue=8&rft.spage=1472&rft.epage=1484&rft_id=info:doi/10.1038%2Fnpp.2013.46&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-133X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-133X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-133X&client=summon |